173 related articles for article (PubMed ID: 30518498)
1. Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study.
Thorneloe RJ; Horne R; Side L; Wolf MS; Smith SG;
Clin Breast Cancer; 2019 Feb; 19(1):e116-e126. PubMed ID: 30518498
[TBL] [Abstract][Full Text] [Related]
2. Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.
Hackett J; Thorneloe R; Side L; Wolf M; Horne R; Cuzick J; Smith SG
Breast Cancer Res Treat; 2018 Aug; 170(3):633-640. PubMed ID: 29687178
[TBL] [Abstract][Full Text] [Related]
3. Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy.
Thorneloe RJ; Hall LH; Walter FM; Side L; Lloyd KE; Smith SG;
Cancer Prev Res (Phila); 2020 Apr; 13(4):411-422. PubMed ID: 31988145
[TBL] [Abstract][Full Text] [Related]
4. Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer.
Salgado TM; Davis EJ; Farris KB; Fawaz S; Batra P; Henry NL
Breast Cancer Res Treat; 2017 Jun; 163(2):311-319. PubMed ID: 28251384
[TBL] [Abstract][Full Text] [Related]
5. Understanding tamoxifen adherence in women with breast cancer: A qualitative study.
Moon Z; Moss-Morris R; Hunter MS; Hughes LD
Br J Health Psychol; 2017 Nov; 22(4):978-997. PubMed ID: 28850763
[TBL] [Abstract][Full Text] [Related]
6. Understanding Breast Cancer Survivors' Beliefs and Concerns About Adjuvant Hormonal Therapy: Promoting Adherence.
Hurtado-de-Mendoza A; Jensen RE; Jennings Y; Sheppard VB
J Cancer Educ; 2018 Apr; 33(2):436-439. PubMed ID: 28205022
[TBL] [Abstract][Full Text] [Related]
7. More than just side-effects: The role of clinical and psychosocial factors in non-adherence to tamoxifen.
Moon Z; Moss-Morris R; Hunter MS; Hughes LD
Br J Health Psychol; 2017 Nov; 22(4):998-1018. PubMed ID: 28940998
[TBL] [Abstract][Full Text] [Related]
8. Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).
Smith SG; Sestak I; Howell A; Forbes J; Cuzick J
J Clin Oncol; 2017 Aug; 35(23):2666-2673. PubMed ID: 28661758
[TBL] [Abstract][Full Text] [Related]
9. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder.
Emilsson M; Gustafsson PA; Öhnström G; Marteinsdottir I
Eur Child Adolesc Psychiatry; 2017 May; 26(5):559-571. PubMed ID: 27848023
[TBL] [Abstract][Full Text] [Related]
10. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
11. Affective forecasting and medication decision making in breast-cancer prevention.
Hoerger M; Scherer LD; Fagerlin A
Health Psychol; 2016 Jun; 35(6):594-603. PubMed ID: 26867042
[TBL] [Abstract][Full Text] [Related]
12. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
[TBL] [Abstract][Full Text] [Related]
13. Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer.
Corter AL; Findlay M; Broom R; Porter D; Petrie KJ
Br J Health Psychol; 2013 Feb; 18(1):168-81. PubMed ID: 23134580
[TBL] [Abstract][Full Text] [Related]
14. What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy.
Heisig SR; Shedden-Mora MC; von Blanckenburg P; Rief W; Witzel I; Albert US; Nestoriuc Y
Psychooncology; 2016 Dec; 25(12):1485-1492. PubMed ID: 26913587
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.
Smith SG; Sestak I; Forster A; Partridge A; Side L; Wolf MS; Horne R; Wardle J; Cuzick J
Ann Oncol; 2016 Apr; 27(4):575-90. PubMed ID: 26646754
[TBL] [Abstract][Full Text] [Related]
16. Beliefs about medicines in pregnancy: a survey using the beliefs about medicines questionnaire in Indonesia.
Nugraheni G; Sulistyarini A; Zairina E
Int J Clin Pharm; 2020 Feb; 42(1):57-64. PubMed ID: 31721039
[TBL] [Abstract][Full Text] [Related]
17. Factors implicated in the decision whether or not to join the tamoxifen trial in women at high familial risk of breast cancer.
Lovegrove E; Rumsey N; Harcourt D; Cawthorn SJ
Psychooncology; 2000; 9(3):193-202. PubMed ID: 10871715
[TBL] [Abstract][Full Text] [Related]
18. Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes.
Smith SG; Foy R; McGowan JA; Kobayashi LC; de Censi A; DeCensi A; Brown K; Side L; Cuzick J
Br J Gen Pract; 2017 Jun; 67(659):e414-e427. PubMed ID: 28193617
[TBL] [Abstract][Full Text] [Related]
19. Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: nature and relevance for non-adherence.
Wouters H; van Geffen EC; Baas-Thijssen MC; Krol-Warmerdam EM; Stiggelbout AM; Belitser S; Bouvy ML; van Dijk L
Breast; 2013 Oct; 22(5):661-6. PubMed ID: 23770134
[TBL] [Abstract][Full Text] [Related]
20. Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.
Korfage IJ; Fuhrel-Forbis A; Ubel PA; Zikmund-Fisher BJ; Greene SM; McClure JB; Smith DM; Alford SH; Fagerlin A
Breast Cancer Res; 2013; 15(5):R74. PubMed ID: 24004815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
